Global Inactivated Poliovirus Vaccine Market Research Report 2025(Status and Outlook)

March 2025 | 198 pages | ID: GB1527CA0567EN
Bosson Research

Abstracts

Report Overview

Inactivated polio vaccine (IPV) IPV is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin.

This report provides a deep insight into the global Inactivated Poliovirus Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Inactivated Poliovirus Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Inactivated Poliovirus Vaccine market in any manner.

Global Inactivated Poliovirus Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Sanofi

GSK

Serum Institute (Bilthoven Biologicals)

IMBCA

Market Segmentation (by Type)

Human Diploid Cell

Monkey Kidney Cell

Market Segmentation (by Application)

Public

Private

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Inactivated Poliovirus Vaccine Market
• Overview of the regional outlook of the Inactivated Poliovirus Vaccine Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Inactivated Poliovirus Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Inactivated Poliovirus Vaccine
1.2 Key Market Segments
1.2.1 Inactivated Poliovirus Vaccine Segment by Type
1.2.2 Inactivated Poliovirus Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Inactivated Poliovirus Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Inactivated Poliovirus Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Inactivated Poliovirus Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Inactivated Poliovirus Vaccine Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Inactivated Poliovirus Vaccine Product Life Cycle
3.3 Global Inactivated Poliovirus Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Inactivated Poliovirus Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Inactivated Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Inactivated Poliovirus Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Inactivated Poliovirus Vaccine Manufacturing Sites, Area Served, Product Type
3.8 Inactivated Poliovirus Vaccine Market Competitive Situation and Trends
3.8.1 Inactivated Poliovirus Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Inactivated Poliovirus Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Inactivated Poliovirus Vaccine Industry Chain Analysis
4.1 Inactivated Poliovirus Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Inactivated Poliovirus Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Inactivated Poliovirus Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Inactivated Poliovirus Vaccine Market
5.7 ESG Ratings of Leading Companies
6 Global Inactivated Poliovirus Vaccine Market by Region
6.1 Global Inactivated Poliovirus Vaccine Market Size by Region
6.1.1 Global Inactivated Poliovirus Vaccine Market Size by Region
6.1.2 Global Inactivated Poliovirus Vaccine Market Size Market Share by Region
6.2 Global Inactivated Poliovirus Vaccine Sales by Region
6.2.1 Global Inactivated Poliovirus Vaccine Sales by Region
6.2.2 Global Inactivated Poliovirus Vaccine Sales Market Share by Region
7 North America Market Overview
7.1 North America Inactivated Poliovirus Vaccine Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Inactivated Poliovirus Vaccine Market Size by Type
7.3 North America Inactivated Poliovirus Vaccine Market Size by Application
8 Europe Market Overview
8.1 Europe Inactivated Poliovirus Vaccine Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Inactivated Poliovirus Vaccine Market Size by Type
8.3 Europe Inactivated Poliovirus Vaccine Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Inactivated Poliovirus Vaccine Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Inactivated Poliovirus Vaccine Market Size by Type
9.3 Asia-Pacific Inactivated Poliovirus Vaccine Market Size by Application
10 South America Market Overview
10.1 South America Inactivated Poliovirus Vaccine Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Inactivated Poliovirus Vaccine Market Size by Type
10.3 South America Inactivated Poliovirus Vaccine Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Inactivated Poliovirus Vaccine Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Inactivated Poliovirus Vaccine Market Size by Type
11.3 Middle East and Africa Inactivated Poliovirus Vaccine Market Size by Application
12 Inactivated Poliovirus Vaccine Market Production by Region
12.1 Global Production of Inactivated Poliovirus Vaccine by Region(2020-2025)
12.2 Global Inactivated Poliovirus Vaccine Revenue Market Share by Region (2020-2025)
12.3 Global Inactivated Poliovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Inactivated Poliovirus Vaccine Production
12.4.1 North America Inactivated Poliovirus Vaccine Production Growth Rate (2020-2025)
12.4.2 North America Inactivated Poliovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Inactivated Poliovirus Vaccine Production
12.5.1 Europe Inactivated Poliovirus Vaccine Production Growth Rate (2020-2025)
12.5.2 Europe Inactivated Poliovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Inactivated Poliovirus Vaccine Production (2020-2025)
12.6.1 Japan Inactivated Poliovirus Vaccine Production Growth Rate (2020-2025)
12.6.2 Japan Inactivated Poliovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Inactivated Poliovirus Vaccine Production (2020-2025)
12.7.1 China Inactivated Poliovirus Vaccine Production Growth Rate (2020-2025)
12.7.2 China Inactivated Poliovirus Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
13 Inactivated Poliovirus Vaccine Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Inactivated Poliovirus Vaccine Sales Market Share by Type (2020-2033)
13.3 Global Inactivated Poliovirus Vaccine Market Size Market Share by Type (2020-2033)
13.4 Global Inactivated Poliovirus Vaccine Price by Type (2020-2033)
14 Inactivated Poliovirus Vaccine Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Inactivated Poliovirus Vaccine Market Sales by Application (2020-2033)
14.3 Global Inactivated Poliovirus Vaccine Market Size (M USD) by Application (2020-2033)
14.4 Global Inactivated Poliovirus Vaccine Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Sanofi
15.1.1 Sanofi Basic Information
15.1.2 Sanofi Inactivated Poliovirus Vaccine Product Overview
15.1.3 Sanofi Inactivated Poliovirus Vaccine Product Market Performance
15.1.4 Sanofi Business Overview
15.1.5 Sanofi SWOT Analysis
15.1.6 Sanofi Recent Developments
15.2 GSK
15.2.1 GSK Basic Information
15.2.2 GSK Inactivated Poliovirus Vaccine Product Overview
15.2.3 GSK Inactivated Poliovirus Vaccine Product Market Performance
15.2.4 GSK Business Overview
15.2.5 GSK SWOT Analysis
15.2.6 GSK Recent Developments
15.3 Serum Institute (Bilthoven Biologicals)
15.3.1 Serum Institute (Bilthoven Biologicals) Basic Information
15.3.2 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Product Overview
15.3.3 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Product Market Performance
15.3.4 Serum Institute (Bilthoven Biologicals) Business Overview
15.3.5 Serum Institute (Bilthoven Biologicals) SWOT Analysis
15.3.6 Serum Institute (Bilthoven Biologicals) Recent Developments
15.4 IMBCA
15.4.1 IMBCA Basic Information
15.4.2 IMBCA Inactivated Poliovirus Vaccine Product Overview
15.4.3 IMBCA Inactivated Poliovirus Vaccine Product Market Performance
15.4.4 IMBCA Business Overview
15.4.5 IMBCA Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Inactivated Poliovirus Vaccine Market Size by Type (M USD)
Table 4. Global Inactivated Poliovirus Vaccine Market Size by Application (M USD)
Table 5. Inactivated Poliovirus Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Inactivated Poliovirus Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Inactivated Poliovirus Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Inactivated Poliovirus Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Inactivated Poliovirus Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Poliovirus Vaccine as of 2024)
Table 11. Global Market Inactivated Poliovirus Vaccine Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Inactivated Poliovirus Vaccine Manufacturing Sites and Area Served
Table 13. Manufacturers Inactivated Poliovirus Vaccine Product Type
Table 14. Global Inactivated Poliovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Inactivated Poliovirus Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Inactivated Poliovirus Vaccine Market Size Comparison by Region (M USD)
Table 26. Global Inactivated Poliovirus Vaccine Market Size by Region (2020-2033) & (M USD)
Table 27. Global Inactivated Poliovirus Vaccine Market Size Market Share by Region (2020-2033)
Table 28. Global Inactivated Poliovirus Vaccine Sales by Region (2020-2033) & (K MT)
Table 29. Global Inactivated Poliovirus Vaccine Sales Market Share by Region (2020-2033)
Table 30. North America Inactivated Poliovirus Vaccine Market Size by Country (2020-2033) & (M USD)
Table 31. North America Inactivated Poliovirus Vaccine Sales by Country (2020-2033) & (K MT)
Table 32. North America Inactivated Poliovirus Vaccine Sales by Type (K MT)
Table 33. North America Inactivated Poliovirus Vaccine Market Size by Type (M USD)
Table 34. North America Inactivated Poliovirus Vaccine Sales (K MT) by Type (2020-2033)
Table 35. North America Inactivated Poliovirus Vaccine Market Size (M USD) by Type (2020-2033)
Table 36. North America Inactivated Poliovirus Vaccine Sales by Application (K MT)
Table 37. North America Inactivated Poliovirus Vaccine Market Size by Application (M USD)
Table 38. North America Inactivated Poliovirus Vaccine Sales (K MT) by Application (2020-2033)
Table 39. North America Inactivated Poliovirus Vaccine Market Size (M USD) by Application (2020-2033)
Table 40. Europe Inactivated Poliovirus Vaccine Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Inactivated Poliovirus Vaccine Sales by Country (2020-2033) & (K MT)
Table 42. Europe Inactivated Poliovirus Vaccine Sales by Type (K MT)
Table 43. Europe Inactivated Poliovirus Vaccine Market Size by Type (M USD)
Table 44. Europe Inactivated Poliovirus Vaccine Sales (K MT) by Type (2020-2033)
Table 45. Europe Inactivated Poliovirus Vaccine Market Size (M USD) by Type (2020-2033)
Table 46. Europe Inactivated Poliovirus Vaccine Sales by Application (K MT)
Table 47. Europe Inactivated Poliovirus Vaccine Market Size by Application (M USD)
Table 48. Europe Inactivated Poliovirus Vaccine Sales (K MT) by Application (2020-2033)
Table 49. Europe Inactivated Poliovirus Vaccine Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Inactivated Poliovirus Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Inactivated Poliovirus Vaccine Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Inactivated Poliovirus Vaccine Sales by Type (K MT)
Table 53. Asia-Pacific Inactivated Poliovirus Vaccine Market Size by Type (M USD)
Table 54. Asia-Pacific Inactivated Poliovirus Vaccine Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Inactivated Poliovirus Vaccine Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Inactivated Poliovirus Vaccine Sales by Application (K MT)
Table 57. Asia-Pacific Inactivated Poliovirus Vaccine Market Size by Application (M USD)
Table 58. Asia-Pacific Inactivated Poliovirus Vaccine Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Inactivated Poliovirus Vaccine Market Size (M USD) by Application (2020-2025)
Table 60. South America Inactivated Poliovirus Vaccine Market Size by Country (2020-2033) & (M USD)
Table 61. South America Inactivated Poliovirus Vaccine Sales by Country (2020-2033) & (K MT)
Table 62. South America Inactivated Poliovirus Vaccine Sales by Type (K MT)
Table 63. South America Inactivated Poliovirus Vaccine Market Size by Type (M USD)
Table 64. South America Inactivated Poliovirus Vaccine Sales (K MT) by Type (2020-2033)
Table 65. South America Inactivated Poliovirus Vaccine Market Size (M USD) by Type (2020-2033)
Table 66. South America Inactivated Poliovirus Vaccine Sales by Application (K MT)
Table 67. South America Inactivated Poliovirus Vaccine Market Size by Application (M USD)
Table 68. South America Inactivated Poliovirus Vaccine Sales (K MT) by Application (2020-2033)
Table 69. South America Inactivated Poliovirus Vaccine Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Inactivated Poliovirus Vaccine Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Inactivated Poliovirus Vaccine Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Inactivated Poliovirus Vaccine Sales by Type (K MT)
Table 73. Middle East and Africa Inactivated Poliovirus Vaccine Market Size by Type (M USD)
Table 74. Middle East and Africa Inactivated Poliovirus Vaccine Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Inactivated Poliovirus Vaccine Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Inactivated Poliovirus Vaccine Sales by Application (K MT)
Table 77. Middle East and Africa Inactivated Poliovirus Vaccine Market Size by Application (M USD)
Table 78. Middle East and Africa Inactivated Poliovirus Vaccine Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Inactivated Poliovirus Vaccine Market Size (M USD) by Application (2020-2033)
Table 80. Global Inactivated Poliovirus Vaccine Production (K MT) by Region(2020-2025)
Table 81. Global Inactivated Poliovirus Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Inactivated Poliovirus Vaccine Revenue Market Share by Region (2020-2025)
Table 83. Global Inactivated Poliovirus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Inactivated Poliovirus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Inactivated Poliovirus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Inactivated Poliovirus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Inactivated Poliovirus Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Inactivated Poliovirus Vaccine Sales by Type (K MT)
Table 89. Global Inactivated Poliovirus Vaccine Market Size by Type (M USD)
Table 90. Global Inactivated Poliovirus Vaccine Sales (K MT) by Type (2020-2033)
Table 91. Global Inactivated Poliovirus Vaccine Sales Market Share by Type (2020-2033)
Table 92. Global Inactivated Poliovirus Vaccine Market Size (M USD) by Type (2020-2033)
Table 93. Global Inactivated Poliovirus Vaccine Market Size Share by Type (2020-2033)
Table 94. Global Inactivated Poliovirus Vaccine Sales (K MT) by Application
Table 95. Global Inactivated Poliovirus Vaccine Market Size by Application(M USD)
Table 96. Global Inactivated Poliovirus Vaccine Sales by Application (2020-2033) & (K MT)
Table 97. Global Inactivated Poliovirus Vaccine Sales Market Share by Application (2020-2033)
Table 98. Global Inactivated Poliovirus Vaccine Market Size by Application (2020-2033) & (M USD)
Table 99. Global Inactivated Poliovirus Vaccine Market Share by Application (2020-2033)
Table 100. Global Inactivated Poliovirus Vaccine Sales Growth Rate by Application (2020-2033)
Table 101. Sanofi Basic Information
Table 102. Sanofi Inactivated Poliovirus Vaccine Product Overview
Table 103. Sanofi Inactivated Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Sanofi Business Overview
Table 105. Sanofi SWOT Analysis
Table 106. Sanofi Recent Developments
Table 107. GSK Basic Information
Table 108. GSK Inactivated Poliovirus Vaccine Product Overview
Table 109. GSK Inactivated Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. GSK Business Overview
Table 111. GSK SWOT Analysis
Table 112. GSK Recent Developments
Table 113. Serum Institute (Bilthoven Biologicals) Basic Information
Table 114. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Product Overview
Table 115. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Serum Institute (Bilthoven Biologicals) Business Overview
Table 117. Serum Institute (Bilthoven Biologicals) SWOT Analysis
Table 118. Serum Institute (Bilthoven Biologicals) Recent Developments
Table 119. IMBCA Basic Information
Table 120. IMBCA Inactivated Poliovirus Vaccine Product Overview
Table 121. IMBCA Inactivated Poliovirus Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. IMBCA Business Overview
Table 123. IMBCA Recent Developments
List of Figures
Figure 1. Product Picture of Inactivated Poliovirus Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Inactivated Poliovirus Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Inactivated Poliovirus Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Inactivated Poliovirus Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Inactivated Poliovirus Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Inactivated Poliovirus Vaccine Product Life Cycle
Figure 13. Inactivated Poliovirus Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Inactivated Poliovirus Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Inactivated Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Inactivated Poliovirus Vaccine Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Inactivated Poliovirus Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Inactivated Poliovirus Vaccine
Figure 19. Global Inactivated Poliovirus Vaccine Market PEST Analysis
Figure 20. Global Inactivated Poliovirus Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Inactivated Poliovirus Vaccine Market Size by Region
Figure 27. Global Inactivated Poliovirus Vaccine Market Size Market Share by Region (2020-2033)
Figure 28. Global Inactivated Poliovirus Vaccine Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Inactivated Poliovirus Vaccine Market Size (M USD) by Country
Figure 33. USA Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Inactivated Poliovirus Vaccine Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Inactivated Poliovirus Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Inactivated Poliovirus Vaccine Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Inactivated Poliovirus Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Inactivated Poliovirus Vaccine Market Size (M USD)by Type
Figure 40. North America Inactivated Poliovirus Vaccine Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Inactivated Poliovirus Vaccine Market Size (M USD) by Country
Figure 45. Germany Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Inactivated Poliovirus Vaccine Market Size (M USD) by Type
Figure 56. Europe Inactivated Poliovirus Vaccine Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Inactivated Poliovirus Vaccine Market Size (M USD) by Country
Figure 61. China Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Inactivated Poliovirus Vaccine Market Size (M USD) by Type
Figure 72. Asia-Pacific Inactivated Poliovirus Vaccine Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Inactivated Poliovirus Vaccine Market Size (M USD) by Country
Figure 77. Brazil Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Inactivated Poliovirus Vaccine Market Size (M USD) by Type
Figure 84. South America Inactivated Poliovirus Vaccine Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Inactivated Poliovirus Vaccine Market Size (M USD) by Country
Figure 89. Saudi Arabia Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Inactivated Poliovirus Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Inactivated Poliovirus Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Inactivated Poliovirus Vaccine Market Size (M USD) by Type
Figure 100. Middle East and Africa Inactivated Poliovirus Vaccine Market Size (M USD) by Application
Figure 101. Global Inactivated Poliovirus Vaccine Production Market Share by Region (2020-2025)
Figure 102. North America Inactivated Poliovirus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Inactivated Poliovirus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Inactivated Poliovirus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. China Inactivated Poliovirus Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Inactivated Poliovirus Vaccine Market Size by Type (M USD)
Figure 108. Sales Market Share of Inactivated Poliovirus Vaccine by Type (2020-2033)
Figure 109. Sales Market Share of Inactivated Poliovirus Vaccine by Type in 2024
Figure 110. Market Size Share of Inactivated Poliovirus Vaccine by Type (2020-2033)
Figure 111. Market Size Share of Inactivated Poliovirus Vaccine by Type in 2024
Figure 112. Global Inactivated Poliovirus Vaccine Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Inactivated Poliovirus Vaccine Market Size by Application(M USD)
Figure 115. Global Inactivated Poliovirus Vaccine Market Share by Application
Figure 116. Global Inactivated Poliovirus Vaccine Sales Market Share by Application (2020-2033)
Figure 117. Global Inactivated Poliovirus Vaccine Sales Market Share by Application in 2024
Figure 118. Global Inactivated Poliovirus Vaccine Market Share by Application (2020-2033)
Figure 119. Global Inactivated Poliovirus Vaccine Market Share by Application in 2024
Figure 120. Global Inactivated Poliovirus Vaccine Sales Growth Rate by Application (2020-2033)